News

The FDA is reviewing clinical trials that send US patients' cells to foreign labs, citing concerns over genetic data security. Learn more about the new regulations.

To reveal the science behind the protein–nanoparticle interaction and its implications for human health, a team of researchers conducted a series of spectroscopy-based experiments.

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide.

Two studies unveiled at the 85th Scientific Sessions of the American Diabetes Association in Chicago point to progress in developing stem cell-based treatments for type 1 diabetes.

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine could revolutionize how hospitals treat rare diseases, even in low-resource settings.

A pretreatment step could help transplanted pancreatic isle cells survive longer in patients with type 1 diabetes, according to a new preclinical study,

A University of Sydney study uncovers the critical role of the Zelda gene in ensuring successful tissue regeneration. Researchers found that Zelda helps guide proper tissue recovery and prevents mistakes during regeneration.

A new study suggests that receiving updated COVID-19 vaccines remains crucial, especially for older adults and those at increased risk for severe outcomes and underscores the additional protection provided by the updated COVID-19 vaccines.

Skin grafts genetically engineered from a patient’s own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown.